Aravali Pharma and Lifesciences is a team of subject matter experts with more than three decades of experience in drug discovery and development. We provide end-to-end comprehensive solutions that equip our clients to innovate and succeed.
Pragya Bhateja, PhD
Founding Managing Director
Dr. Pragya is one of the founding members of Aravali Pharma and Lifesciences. Prior to initiation of Aravali, she held multiple senior strategic positions in global organizations such as Ranbaxy Research Laboratories and Daiichi Sankyo India Pharma Pvt Ltd. Dr. Pragya specializes in microbiology and anti-infective drug discovery. Over last two decades she executed and managed a portfolio from early target validation to late phase development. To her credit, she initiated, validated and successfully executed exclusive targets for therapeutic intervention. She has a practical approach, in identifying and strategizing unexplored opportunities in biomedical research in order to bring innovative medicines to the market. Her research focuses on screening of small molecules and developing assays for identification and validation of novel targets. Dr. Pragya has a Ph. D in microbiology from Jamia Millia Islamia University, New Delhi, India.
“She strongly believes that innovation is in everyone's DNA its just a matter of harnessing it in the right way through marrying human expertize and technology”.
Tridib Chaira, M Pharm
Founding Managing Director
Mr. Tridib has two decades of drug discovery experience in ADME and PK, modeling and simulation. He has experience working with several multinational companies such as Zydus Research Center, Ranbaxy Research Laboratories, Daiichi Sankyo India Pharma Pvt Ltd. Prior to founding Aravali Pharma and Lifesciences, he worked with Ranbaxy and Daiichi Sankyo for 15 years. There he worked as assistant director and led a team of the researchers providing in-life PK support, PK/PD modeling and simulation and human dose prediction for several projects in infection and airway disease area. Tridib has successfully led several projects from early discovery to "First-in-Human" studies addressing ADME, PK, human dose and DDI risk. Tridib has a Bachelors and Masters in pharmaceutical sciences from Birla Institute of Technology, Mesra.